Explorer

Feluda Is Back! This Time To Detect Covid-19 Infection; Tata CRISPR's Test Gets DCGI Approval For Commercial Launch

Feluda has received regulatory approvals today from DCGI for commercial launch, as per ICMR guidelines, meeting high-quality benchmarks with 96 percent sensitivity and 98 percent specificity for detecting novel coronavirus.

New Delhi: 'Feluda', the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) Covid-19 test, has been approved by the Drugs Controller General of India, the Council of Scientific and Industrial Research (CSIR) announced on Saturday. ALSO READ | India's Covid Tally Breaches 54 Lakh Mark With A Spike Of 92K Cases, Recovery Rate At 79.67 % Highest In The World For the uninitiated, the name 'Feluda' has perhaps been chosen as the name also belongs to a popular Indian detective character on the lines of Sherlock Holmes, in stories written by legendary writer-filmmaker Satyajit Ray. Indigenously developed, cutting-edge CRISPR technology has been put to use for the detection of the genomic sequence of the SARS-CoV-2 virus. The Tata CRISPR test achieves accuracy levels of traditional RT-PCR tests with quicker turnaround time, less expensive equipment and better ease of use. CRISPR is a genome-editing technology to diagnose diseases and has been developed by CSIR-IGIB (Institute of Genomics and Integrative Biology). ALSO READ | Every American Will Get Covid-19 Vaccine By April 2021, Says US President Donald Trump "The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test, powered by CSIR-IGIB (Institute of Genomics and Integrative Biology) FELUDA, received regulatory approvals today from DCGI for commercial launch, as per ICMR guidelines, meeting high-quality benchmarks with 96 percent sensitivity and 98 percent specificity for detecting novel coronavirus," the statement said. The Tata CRISPR test is the world's first diagnostic test to deploy a specially adapted Cas9 protein to successfully detect the virus causing COVID-19, it stated. Furthermore, CRISPR is a futuristic technology that can be used for the detection of multiple other pathogens in the future. "The Tata Group has worked closely with CSIR-IGIB and ICMR to create a high-quality test that will help the nation ramp up COVID-19 testing quickly and economically, with a "Made in India" product that is safe, reliable, affordable and accessible," the statement added. Taking about the launch, Girish Krishnamurthy, CEO, TATA Medical and Diagnostics Ltd said, "The approval for the Tata CRISPR test for Covid-19 will give a boost to the country's efforts in fighting the global pandemic. "The commercialization of the Tata CRISPR test reflects the tremendous R&D talent in the country which can collaborate to transform India's contributions to the global healthcare and scientific research world," he said. (With Agency Inputs) WATCH | Prayagraj: Police Officials keeping an eye on field officers via Google Meet

Check out below Health Tools-
Calculate Your Body Mass Index ( BMI )

Calculate The Age Through Age Calculator

Top Headlines

What 5-Year-Olds Should Eat For Brain Development And Strong Bones, WHO Explains
What 5-Year-Olds Should Eat For Brain Development And Strong Bones, WHO Explains
Doc Talk | No Asthma, No Smoking, Still Breathless? How Delhi-NCR's Air Quality Affects Healthy Lungs
Doc Talk | No Asthma, No Smoking, Still Breathless? How Delhi-NCR's Air Quality Affects Healthy Lungs
Eating Healthy At Home? Why You May Still Be At Risk Of Type 2 Diabetes
Eating Healthy At Home? Why You May Still Be At Risk Of Type 2 Diabetes
India's Healthcare Spending Triples To Rs 4.14 Lakh Crore In 10 Years, OOPE Drops To 42.7%
India's Healthcare Spending Triples To Rs 4.14 Lakh Crore In 10 Years, OOPE Drops To 42.7%

Videos

Massive Fire: Fierce Blaze Engulfs Platinum Logistics Warehouse in Maharashtra’s Raigad
Congress Meeting: Harish Rawat Called to Kharge’s Residence Amid Resentment Reports
Big Question: Was Amitabh Bachchan Among the Targets of the Two Arrested Shooters?
UP Strategy: Congress Holds High-Level Meeting at Mallikarjun Kharge’s Residence
BJP Attack: Gaurav Bhatia Calls Hyderabad India Summit an “Anti-India” Event

Photo Gallery

25°C
New Delhi
Rain: 100mm
Humidity: 97%
Wind: WNW 47km/h
See Today's Weather
powered by
Accu Weather
Embed widget